Assyro AI

Orange Book product · Generic (ANDA)

IFOSFAMIDE

IFOSFAMIDE

Generic (ANDA)ANDA 076657TE APRX MEITHEAL

At a glance

Apr 04, 2007

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 04, 2007

    19 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IFOSFAMIDE

Strength

3GM/60ML (50MG/ML)

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 076657

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of IFOSFAMIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.